Valoctocogene roxaparvovec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Valoctocogene roxaparvovec, covering 2021-10-08 to 2021-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg [Phase 3]